May Zin War War, Buttachon Suradet, Dethoup Tida, Fernandes Carla, Cravo Sara, Pinto Madalena M M, Gales Luís, Pereira José A, Silva Artur M S, Sekeroglu Nazim, Kijjoa Anake
<i>ICBAS</i>-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), Rua dos Bragas 289, 4050-313 Porto, Portugal.
Mar Drugs. 2016 Jul 20;14(7):136. doi: 10.3390/md14070136.
Two new cyclotetrapeptides, sartoryglabramides A (5) and B (6), and a new analog of fellutanine A (8) were isolated, together with six known compounds including ergosta-4, 6, 8 (14), 22-tetraen-3-one, ergosterol 5, 8-endoperoxide, helvolic acid, aszonalenin (1), (3R)-3-(1H-indol-3-ylmethyl)-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione (2), takakiamide (3), (11aR)-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione (4), and fellutanine A (7), from the ethyl acetate extract of the culture of the marine sponge-associated fungus Neosartorya glabra KUFA 0702. The structures of the new compounds were established based on extensive 1D and 2D spectral analysis. X-ray analysis was also used to confirm the relative configuration of the amino acid constituents of sartoryglabramide A (5), and the absolute stereochemistry of the amino acid constituents of sartoryglabramide A (5) and sartoryglabramides B (6) was determined by chiral HPLC analysis of their hydrolysates by co-injection with the d- and l- amino acids standards. Compounds 1-8 were tested for their antibacterial activity against Gram-positive (Escherichia coli ATCC 25922) and Gram-negative (Staphyllococus aureus ATCC 25923) bacteria, as well as for their antifungal activity against filamentous (Aspergillus fumigatus ATCC 46645), dermatophyte (Trichophyton rubrum ATCC FF5) and yeast (Candida albicans ATCC 10231). None of the tested compounds exhibited either antibacterial (MIC > 256 μg/mL) or antifungal activities (MIC > 512 μg/mL).
从海洋海绵共生真菌新萨托菌(Neosartorya glabra)KUFA 0702培养物的乙酸乙酯提取物中分离得到了两种新的环四肽,即萨托里格拉布酰胺A(5)和B(6),以及一种新的费卢他宁A类似物(8),同时还分离得到了六种已知化合物,包括麦角甾-4,6,8(14),22-四烯-3-酮、麦角甾醇5,8-内过氧化物、蜂窝酸、阿佐拉宁(1)、(3R)-3-(1H-吲哚-3-基甲基)-3,4-二氢-1H-1,4-苯并二氮杂卓-2,5-二酮(2)、高木酰胺(3)、(11aR)-2,3-二氢-1H-吡咯并[2,1-c][1,4]苯并二氮杂卓-5,11(10H,11aH)-二酮(4)和费卢他宁A(7)。基于广泛的一维和二维光谱分析确定了新化合物的结构。还使用X射线分析来确认萨托里格拉布酰胺A(5)氨基酸成分的相对构型,并通过将其水解产物与d-和l-氨基酸标准品共注入进行手性HPLC分析来确定萨托里格拉布酰胺A(5)和萨托里格拉布酰胺B(6)氨基酸成分的绝对立体化学。测试了化合物1-8对革兰氏阳性菌(大肠杆菌ATCC 25922)和革兰氏阴性菌(金黄色葡萄球菌ATCC 25923)的抗菌活性,以及对丝状真菌(烟曲霉ATCC 46645)、皮肤癣菌(红色毛癣菌ATCC FF5)和酵母(白色念珠菌ATCC 10231)的抗真菌活性。所测试的化合物均未表现出抗菌活性(MIC>256μg/mL)或抗真菌活性(MIC>512μg/mL)。